Drug recall · May 2, 2018
Diltiazem CD recall
Why: Failed Dissolution Specifications. High dissolution results were obtained during stability testing.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Diltiazem CD (Diltiazem Hydrochloride Extended-Release Capsules, USP) 180 mg, 100-count bottles, Rx Only Mfg. By: Actavis 60 Columbia Rd., Bldg. B Morristown, NJ 07960. NDC 63739-284-10
- Lots / codes
Lot #: 0114214, Exp. 09/2018
- Quantity
- 7656 cartons
- Company
- Mckesson Packaging Services, Concord, NC
- Distribution
- Nationwide with the US
- Initiated
- April 23, 2018 · Voluntary: Firm initiated
- Classified
- May 7, 2018
- Reported
- May 2, 2018
- Ended
- October 13, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Diltiazem
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.